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function of the aortic valve and no further growth or additional
tumor growth after cardiac surgery.
Discussion
This case describes a patient with the unusual finding of mul-
tiple cardiac fibroelastomas involving the mitral valve and the
LVOT in addition to an altered aortic valve after prior valve
endocarditis. We hypothesize that the local accumulation of
mobile structures might be, at least in part, because of the
congenital altered bicuspid aortic valve and consecutive inflam-
matory alteration. Furthermore, accelerated by aortic regurgi-
tations, jet lesions in the subvalvular region of the mitral valve
and the adjacent left ventricle might have contributed to the
development of the tumor. After surgical replacement of the
formerly infected aortic valve, tumor growth appeared to dis-
continue.
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Facile conversion from mechanical to
bioprosthetic composite aortic root replacement
Luca A. Vricella, MD, and Duke E. Cameron, MD, Baltimore, Md
Aortic root replacement with a composite valve graftmechanical prosthesis has become established therapyfor acute and chronic pathology that eventually leads toenlargement, dissection, or rupture of the aortic root.
Although minimal early and late morbidity and mortality have been
reported, some patients
will require operative
reintervention on the
neoaortic root, with the
goal of conversion from
a mechanical to a xeno-
graft aortic valve prosthesis.
We describe an easily reproducible technique that aims at
minimizing the degree of complexity of such reintervention while
still achieving the goal of freedom from anticoagulation.
Clinical Summary
A 38-year-old man with a history of Marfan syndrome and intra-
venous drug abuse presented to our institution in 1999 with symp-
tomatic aneurysmal dilation of the aortic root and aortic regurgi-
tation and underwent aortic root replacement with a 27-mm
composite mechanical valved prosthesis (St Jude Medical, St Paul,
Minn). Despite enrollment in a drug rehabilitation program, the
From the Division of Cardiac Surgery, The Johns Hopkins Medical Insti-
tutions, Baltimore, Md.
Received for publication Oct 12, 2006; accepted for publication Oct 24,
2006.
Address for reprints: Luca A. Vricella, MD, FACS, Division of Cardiac
Surgery, The Johns Hopkins Hospital, 600 N Wolfe St, Blalock 618,
Baltimore, MD 21287 (E-mail: lvricella@jhmi.edu).
J Thorac Cardiovasc Surg 2007;133:565-7
0022-5223/$32.00
Copyright © 2007 by The American Association for Thoracic Surgery
doi:10.1016/j.jtcvs.2006.10.024
Figure 2. A, Transesophageal 2-chamber view. AML, Anterior
mitral leaflet; LAA, left atrial appendage; LV, left ventricle. B,
Transesophageal-transgastric long-axis view. PM, Papillary mus-
cle; LA, left atrium; AV, aortic valve.
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patient was lost to follow-up and presented in September of 2003
with congestive heart failure. Reportedly, he had discontinued oral
anticoagulation for 6 months while continuing intravenous drug
abuse. Preoperative workup revealed his mechanical prosthesis to
be frozen in the open position, with massive aortic regurgitation
and an estimated ejection fraction of 15%. Blood culture results
were negative.
At the time of the operation, the aortic root was exposed after
redo sternotomy and takedown of very tenacious adhesions. Rather
than proceeding with root replacement with a xenograft or a
homograft with coronary reimplantation, a less-conventional ap-
proach was chosen. The Dacron graft was opened, exposing the
mechanical prosthesis, immobilized by a well-organized clot. To
follow, a 30-mL Foley catheter was inserted within the left ven-
tricular outflow tract and pulled against the inferior margin of the
mechanical prosthesis (Figure 1). The valve leaflets were then
grasped with a clamp and unhinged from the prosthetic housing;
the few prosthetic fragments that were left on the convexity of the
exposed balloon were easily retrieved with suction. The Dacron
portion of the composite valve graft visible below the coronary
ostia was then rimmed with interrupted, horizontal mattress 2-0
braided sutures (Figure 2). The sutures where then passed through
the sewing ring of a 23-mm bovine pericardial valve (Edwards
Lifesciences, Irvine, Calif), which was lowered in place in the
subcoronary position (Figure 3). Cardiopulmonary bypass time
and crossclamp time were 38 and 59 minutes, respectively. The
postoperative course was unremarkable, and the patient was dis-
charged home on postoperative day 6. He is alive and free from
embolic complications 2 years and 7 months postoperatively.
Discussion
Aortic root replacement with a mechanical prosthesis has been
widely used in the treatment of proximal aortic pathology, with
excellent short- and long-term outcomes and limited need for
operative reintervention.1
There are, however, patients who require reoperation and, in
particular, conversion from a mechanical to a biological pros-
thesis because of issues most often related to oral anticoagula-
tion. Poor compliance with warfarin therapy, recurrent throm-
bosis, and anticoagulation-related hemorrhage are the most
frequent clinical issues that prompt consideration for conver-
sion to a bioprosthesis. In patients with valve thrombosis with-
out intolerance to anticoagulants, thrombolysis and thrombec-
tomy are the only alternatives to replacement.
Reintervention to replace an aortic root prosthesis is often a
challenging undertaking because of dense adhesions and the need
for reimplantation of the coronary ostia, and although good out-
comes have been reported in contemporary series,2,3 bleeding or
coronary ischemia in the postoperative phase are distinct possibil-
ities in repeat aortic root replacement. Furthermore, in patients
with decreased myocardial function, such as the patient described,
an expeditious operation with reduced myocardial ischemic and
perfusion times is desirable.
Harada and colleagues4 reported extirpation of a Bjork–Shiley
mechanical valve, root enlargement, and insertion of a mechanical
prosthesis within the cuff of the valve, a concept also reported in
reoperative mitral and aortic replacement by Geha and coworkers.5
In the latter report, the bioprosthetic struts were amputated, and a
mechanical valve was sutured to the prosthetic sewing ring (valve-
Figure 1. The Dacron graft has been incised, and a 30-mL Foley
catheter has been inserted in the left ventricular outflow tract.
The leaflets have been unhinged from the housing of the mechan-
ical aortic root prosthesis.
Figure 3. A 23-mm bovine pericardial prosthesis has been im-
planted, and the mechanical housing is visible in the subvalvar
position.
Figure 2. Double-loaded, horizontal, mattress braided sutures are
then placed circumferentially in the Dacron graft along a hori-
zontal plane between the nadir of the coronary ostia and the
superior margin of the valve housing.
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on-valve technique). With the technique described herein, the
mechanical prosthesis is not removed in its entirety because the
valve housing is left in situ, and the leaflets are simply unhinged.
We have found this not to be an issue with thrombus formation in
this and in 2 additional cases performed at our institution because
the smooth surface of the housing and the high flow within the left
ventricular outflow tract are most likely protective against recur-
rent thrombosis after removal of the leaflets.
The technique reported is reliable, easily reproducible, and
offers reduced crossclamp time, potential for bleeding, and coro-
nary malperfusion to this challenging group of reoperative pa-
tients.
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Bovine jugular vein as a shaped alternative patch material for aortic
augmentation in the Norwood procedure
David G. Healy, MRCSI, Lars Nolke, FRCSI, and Alfred E. Wood, FRCSI, Dublin, Ireland
The Norwood procedure is commonly performed with apatch augmentation of the neoaorta. Homograft pulmo-nary conduits are used, but the opportunity cost of thisscarce resource has prompted the evaluation of alterna-
tives. We have used bovine jugular vein as an alternative aortic
patch augmentation material with early success.
Clinical Summary
The Medtronic Contegra bioprosthesis (Medtronic, Inc, Minneap-
olis, Minn) consists of a bovine jugular vein with a trileaflet
venous valve. It is preserved under minimal pressure (3 mm Hg)
in a 0.25% buffered glutaraldehyde solution and is terminally
sterilized in a formulation of glutaraldehyde and isopropyl alcohol.
It is available in a range of sizes (12–22-mm internal diameter) and
is between 7- and 10-cm long with the valve centered on the
prosthesis. We have used this patch technique in 3 cases of
hypoplastic left heart syndrome, applying the technique described
by Norwood with the Sano modification.1
The Contegra graft is prepared by being rinsed in normal saline
for 15 minutes. No thawing or preclotting is required. While the
patch is cooling, the surgeon prepares it as shown in Figure 1.
The reconstruction was satisfactory and bleeding was within
expected limits in all 3 patients. Delayed sternal closure was
adopted and none required reintervention for bleeding. Echocar-
diographic studies postoperatively demonstrated good anatomic
reconstruction, and they have all survived to hospital discharge and
are awaiting the second stage of palliation.
Discussion
The original Norwood procedure did not use a patch to reconstruct
the aorta. This was instead proposed by Jonas and associates2 in
1986 in a successful attempt to address the commonly associated
hypoplastic arch and aortic coarctation. Contemporary attempts
have even been made to reconstruct the aorta without the use of
any graft material.3 However, the applicability of this technique is
limited by the anatomy of the child. Fifteen percent of patients in
the Ishino series3 required patch material. This group has subse-
quently moved to a patch aortic augmentation technique for this
reason and because of the technical difficulty of a patchless tech-
nique. In addition, the neoaorta reconstructed at this time is ex-
pected to endure for life, and a final shape with physiologic flow
characteristics should continue to be the surgical aim.
Synthetic material for patch aortic augmentation has not been
widely reported, and there are no randomized comparisons be-
tween synthetic material and pulmonary homograft. This may
reflect the perceived established benefits of biological material as
a vascular patch material. Pulmonary homograft for the reconstruc-
tion of the aorta is considered the ideal material because of its good
hemostatic and handling properties and the appropriateness of
using a vessel graft for vascular reconstruction. However, limited
availability of pulmonary homografts has motivated the search for
alternatives. Allograft material is also associated with calcification
and may reduce the transplantation options, as allograft material
used in Norwood procedures is associated with the generation of
cytotoxic antibodies.4
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